A Second-Generation Proteasome Inhibitor and Doxorubicin Modulates IL-6, pSTAT-3 and NF-kappa B Activity in MDA-MB-231 Breast Cancer Cells

Vyas, D; Lopez-Hisijos, N; Shah, P; Deshpande, KS; Basson, MD; Vyas, A; Chaturvedi, LS

Vyas, D (reprint author), Michigan State Univ, Dept Surg, E Lansing, MI 48912 USA.; Vyas, D (reprint author), Michigan State Univ, Dept Pediat, E Lansing, MI 48912 USA.

JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2017; 17 (1): 175

Abstract

Triple-Negative Breast Cancer (TNBC) has a poor prognosis due to lack of targeted therapy. Doxorubicin (DOX) has failed for multiple reasons, includin......

Full Text Link